“Is the Neoadjuvant Docetaxel, Cisplatin and 5-Fluorouracil Regimen Superior to Classic Cisplatin and 5-Fluorouracil for Locoregionally Advanced Nasopharyngeal Carcinoma?”, J. Can. Res. Updates, vol. 2, no. 4, pp.  297–305, Nov. 2013, doi: 10.6000/1929-2279.2013.02.04.8.